Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hsiao Lieu

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Clinical Pharmacology|June 23, 2007
Regadenoson pharmacokinetics and tolerability in subjects with impaired renal functionToufigh Gordi, Brent Blackburn, Hsiao Lieu
Biomarker Insights|July 7, 2009
Biomarkers and Bioassays for Cardiovascular Diseases: Present and FutureDerek S Sim, Hsiao Lieu, Patrick Andre
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|January 23, 2009
Designer natriuretic peptidesCandace Y W Lee, Hsiao Lieu, John C Burnett
Clinical Pharmacokinetics|November 23, 2006
A population pharmacokinetic/pharmacodynamic analysis of regadenoson, an adenosine A2A-receptor agonist, in healthy male volunteersToufigh Gordi, Paul Frohna, Hai-Ling Sun, et al.
Journal of the American College of Cardiology|January 22, 2008
Interaction of caffeine with regadenoson-induced hyperemic myocardial blood flow as measured by positron emission tomography: a randomized, double-blind, placebo-controlled crossover trialOliver Gaemperli, Tiziano Schepis, Pascal Koepfli, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|September 11, 2007
Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trialAmi E Iskandrian, Timothy M Bateman, Luiz Belardinelli, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Clinical Pharmacology|June 23, 2007
Regadenoson pharmacokinetics and tolerability in subjects with impaired renal functionToufigh Gordi, Brent Blackburn, Hsiao Lieu
Biomarker Insights|July 7, 2009
Biomarkers and Bioassays for Cardiovascular Diseases: Present and FutureDerek S Sim, Hsiao Lieu, Patrick Andre
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|January 23, 2009
Designer natriuretic peptidesCandace Y W Lee, Hsiao Lieu, John C Burnett
Clinical Pharmacokinetics|November 23, 2006
A population pharmacokinetic/pharmacodynamic analysis of regadenoson, an adenosine A2A-receptor agonist, in healthy male volunteersToufigh Gordi, Paul Frohna, Hai-Ling Sun, et al.
Journal of the American College of Cardiology|January 22, 2008
Interaction of caffeine with regadenoson-induced hyperemic myocardial blood flow as measured by positron emission tomography: a randomized, double-blind, placebo-controlled crossover trialOliver Gaemperli, Tiziano Schepis, Pascal Koepfli, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|September 11, 2007
Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trialAmi E Iskandrian, Timothy M Bateman, Luiz Belardinelli, et al.
Pageof 1